Dostarlimab-Gxly 50 MG/1 ML Intravenous Solution [JEMPERLI] for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 26 Feb 2024: Trial registered, NCT06278857
  2. 1 Aug 2024: Trial started, NCT06278857

The trials

NCT06278857: SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)

State
Under way
Phase
Phase 2
People
10 planned
Started
1 Aug 2024
Primary completion
30 Jun 2026
Arms
Single Arm
Results
None posted
  1. 26 Feb 2024: Trial registered
  2. 1 Aug 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.